Individuals Stopping Weight-Loss Medications Regain Weight at a Quadrupled Rate Than People Using Diet and Exercise

A recent study suggests that patients who stop using new weight-loss injections like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who end conventional lifestyle programs.

Research printed in a prominent health publication points out that while obese individuals frequently drop a large proportion of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month once they quit.

"Individuals buying such medications must be informed of the danger of fast weight regain when the therapy ends," cautioned lead investigator Dr. Susan Jebb.

This pace of regain means a return to original mass in about 18 months.

Weighing Treatments

The research, which looked at dozens of trials involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.

Researchers note that people who shed pounds through dieting usually have a less rapid weight regain—approximately 100 grams monthly—once they finish.

The Reason for the Rapid Rebound

Nutrition scientists suggest the way of the jabs accounts for the amplified rebound.

These medications copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Sustained high doses of the hormone levels several times higher than normal may cause the system to produce less of its endogenous hormone, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.

"Stopping of this medication results in hunger is no longer kept in check, making overeating much more probable."

A Chronic Condition?

The NHS suggest the injections for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.

Professionals contend that, given the significant potential of relapse, the treatment might need to be ongoing.

This view is supported by pharmaceutical companies, who note that the findings "emphasize the long-term character of obesity," comparing it to managing conditions like high blood pressure.

Patient Accounts

Users who have stopped the medication explain a intense return of cravings.

"It felt as if something that goes on and I was suddenly starving," said a patient.

This challenge is exacerbated if individuals have not established sustainable dietary or behavioural changes during treatment.

Widespread Adoption

Figures indicate that millions of adults in the UK have tried weight-loss jabs in the past year, with desire being substantial.

• Adoption is more common among females than men.
• The middle-aged demographic shows the highest usage rates.
• A large proportion access the drugs through private healthcare rather than public health services.

In conclusion, experts emphasize that while these medications are effective tools for weight loss, they are not a magic cure and lasting health benefits relies on combined behavioural management.